TAS2R14 and esophageal adenocarcinoma: The most notable survival associations were seen for expression of TAS2R14 in adrenocortical carcinoma, esophageal adenocarcinoma, and non-papillary bladder cancer which were significant based on analysis of mean survival difference and Kaplan–Meier analysis.